Description
KLOW is a research blend combining four peptides: GHK-Cu, BPC-157, TB-500 and KPV. Each component has been investigated separately for different aspects of tissue repair, cellular signalling, inflammation and tissue remodelling.
GHK-Cu is a naturally occurring copper-binding peptide studied for its involvement in collagen production, skin and tissue remodelling and repair processes. BPC-157 has been investigated predominantly in laboratory and animal research involving tendon, ligament, muscle, gastrointestinal and vascular repair. TB-500 is associated with thymosin beta-4 research and has been studied for its role in cell migration, blood-vessel formation and tissue regeneration. KPV is a small peptide derived from alpha-MSH that has attracted research interest because of its effects on inflammatory signalling pathways.
In plain English: KLOW brings together four research compounds that are each being investigated for different parts of the body’s repair and recovery processes. Researchers are interested in areas such as tissue healing, collagen and skin maintenance, inflammation, blood-vessel formation and the way cells move and rebuild damaged tissue.
The individual components have different levels of supporting evidence. GHK-Cu has laboratory and some human skin-related research, while much of the evidence surrounding BPC-157, TB-500 and KPV remains laboratory, animal or early-stage research. Although the ingredients have each been studied independently, the complete KLOW combination has not been established as a proven treatment and its combined effects have not been adequately evaluated in controlled human trials.
Supplied by Black Knight Peptides for laboratory and research purposes only.
Not for human consumption.
